Posted on 1/31/18
What You Should Really Examine in Pfizer's Q4 Earnings Results
When Pfizer (NYSE:PFE) reported its third-quarter results in October, the big drugmaker announced a mixture of good news, bad news, and so-so news. Although the company's . . .
Posted on 1/31/18
Celgene Looking Good With Plans for More Growth
Celgene's (NASDAQ:CELG) fourth-quarter report tends to be unsurprising because the company usually offers -- as it did this year -- preliminary revenue and earnings as well . . .
Posted on 1/31/18
ImmuDyne Announces Management Changes & Sale of Legacy Manufacturing Business
NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD), a leader in the development and online marketing of OTC health and wellness products addressing . . .
Posted on 1/31/18
BioHiTech Global Partners with Kinderhook Industries
BioHiTech Global, Inc. ("BioHiTech" or the "Company") (OTCQB: BHTG), a green technology company that develops and deploys cost effective, innovative and disruptive waste management technologies, partners . . .
Posted on 1/31/18
CipherHealth Wins Top Honors in Patient Outreach Category in 2018 Best in KLAS Report
CipherHealth's automated patient engagement platform has received the highest overall score and was recognized as the #1 performer for patient outreach in the 2018 Best in . . .
Posted on 1/30/18
What to Expect in Pfizer's Q4 Earnings Results
While the stock market roared in 2017, Pfizer (NYSE:PFE) turned in a respectable, but not spectacular, performance, with its stock gaining 11.5%. The big pharma company's . . .
Posted on 1/30/18
Eyenovia Announces Closing of $27.3 Million Initial Public Offering
NEW YORK, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology . . .
Posted on 1/30/18
Amarin Announces Proposed Public Offering of American Depositary Shares
BEDMINSTER, N.J., and DUBLIN, Ireland, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced a registered underwritten public offering of its American Depositary . . .
Posted on 1/30/18
Aetna Announces Transaction with Vitality Re IX
HARTFORD, Conn.--(BUSINESS WIRE)--Aetna (NYSE: AET) today announced that it has entered into a four-year reinsurance arrangement with Vitality Re IX Limited as part of its long-term . . .
Posted on 1/29/18
3 Small Biotechs That Big Drugmakers Are Probably Drooling Over
2018 just might be the best time to be a small biotech -- and own shares of small biotech stocks -- than ever before. Despite a . . .
Posted on 1/29/18
5 Things Celgene's Management Just Said That You'll Want to Know
It's been a wild ride for Celgene (NASDAQ:CELG) over the past four months. A once-promising Crohn's disease drug flopped in a late-stage study. Celgene stock tanked . . .
Posted on 1/29/18
Big Biotech Is Bustling With Buyouts
It's been a busy week in biotech. On Monday, Celgene (NASDAQ:CELG) confirmed rumors it was buying Juno Therapeutics (NASDAQ:JUNO) in a deal valued at $9 billion, . . .
Posted on 1/29/18
Is Johnson & Johnson a Safe Stock to Buy?
Johnson & Johnson (NYSE:JNJ) is a healthcare giant that sells over-the-counter products, pharmaceuticals, and medical devices. Its diversification makes it a core holding for many investors, . . .
Posted on 1/29/18
3 Reasons Celgene's Investors Should Applaud the Juno Therapeutics Buyout
In case you missed it, it turns out the rumor was true. Biotech giant Celgene (NASDAQ:CELG)recently announced that it had agreed to acquired Juno Therapeutics (NASDAQ:JUNO) . . .
Posted on 1/29/18
Better Buy: Intrexon Corporation vs. Celgene
Two very different companies are hoping to make their mark in cell therapy. Intrexon Corporation (NYSE:XON) formed its Precigen subsidiary last year to develop gene and . . .
Posted on 1/29/18
Insmed Closes Public Offering
BRIDGEWATER, N.J., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM) announced the closing today of its previously announced public offering of its 1.75% convertible senior . . .
Posted on 1/29/18
Stemline Therapeutics Closes $59.6 Million Public Offering of Common Stock
NEW YORK, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc.(Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced the closing of a previously . . .
Posted on 1/26/18
Price Decline Makes Johnson & Johnson Even More Attractive
Johnson & Johnson (JNJ) reported fourth quarter and full-year 2017 earnings prior to the opening bell on 1/23/2018. Shares dropped 4.25% after earnings were released. Over . . .
Posted on 1/26/18
Johnson & Johnson Down Small on Huge Loss -- What Gives?
On this episode of the Market Foolery podcast, Chris Hill chats with Jim Mueller from Stock Advisor and Motley Fool Options and Abi Malin of Hidden . . .
Posted on 1/26/18
Athenex Prices Offering of Common Stock
BUFFALO, N.Y., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Athenex (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the . . .
Posted on 1/26/18
Eyenovia Prices IPO
NEW YORK, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc., a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology . . .
Posted on 1/26/18
Actinium Pharmaceuticals Issues Letter to Investors
NEW YORK, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) announced today that it has issued a letter to investors providing a company . . .
Posted on 1/26/18
Bain Capital-backed Solid Biosciences Rolls Out IPO
CAMBRIDGE, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:SLDB) today announced the pricing of its initial public offering of 7,812,500 shares of its . . .
Posted on 1/25/18
A Leading US Based Biopharmaceutical Company Signs a Deal with Zycus
PRINCETON, N.J.--(BUSINESS WIRE)--Zycus, a leading global provider of a comprehensive and end-to-end Source-to-Pay suite has today announced that it has signed a deal with the leading . . .
Posted on 1/25/18
ZelisĀ® Healthcare Named as Finalist in 2018 Stevie Awards for Sales & Customer Service
BEDMINSTER, N.J.--(BUSINESS WIRE)--Zelis Healthcare, a market-leading provider of integrated healthcare cost management and payments solutions, is pleased to announce that it was named a Finalist in . . .

